loader2
Partner With Us NRI

Company details

1,285.00
1,325.85
477.35
1,385.90
6M Return 48.84%
1Y Return 171.84%
Mkt Cap.(Cr) 587.71
Volume 970
Div Yield 0.05%
OI
-
OI Chg %
-
Volume 970

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 67.85 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 4,766.50 32,041.69
LAST 3M 28,862.66 46,665.50
LAST 6M 52,909.20 49,493.09
LAST 12M 193,038.46 -134,673.23
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
Sep 16, 2021 Dividend 7

Information

  • About Company
  • Company Info
  • Listing Info
71.47
51.04%
178.0779
12.9%
11.41%
Description
  • Incorported in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.`94. It was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietory firm, for the manufacture and export of pharmaceutical formulations. The exports were mainly to Afghanistan and west Africa. Since 1993, D N Pharma`s operations were phased out in order to switch over the business to FPL. FPL was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane district), Maharashtra, which commenced commercial production in Aug.`94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind. In Apr.`96, the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company`s turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda & Sri Lanka.

Read More

Registered Address

26 Manoj Industrial Premises, G D Ambedkar Marg Wadala, Mumbai, Maharashtra, 400031

Tel : 91-22-40318111
Email : business:fredungroup.com
Website : http://www.fredungroup.com

Registrar

Purva Sharegistry (I) Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 539730
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE194R01017

ICICIdirect Fredun Pharmaceuticals Ltd FAQ

You can buy Fredun Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Fredun Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Dec 02, 2022 04:01 PM the closing price of Fredun Pharmaceuticals Ltd was ₹ 1,319.80.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Dec 02, 2022 04:01 PM, the market cap of Fredun Pharmaceuticals Ltd stood at ₹ 587.71.
The latest PE ratio of Fredun Pharmaceuticals Ltd as of Dec 02, 2022 04:01 PM is 71.47
The latest PB ratio of Fredun Pharmaceuticals Ltd as of Dec 02, 2022 04:01 PM is 0.13
The 52-week high of Fredun Pharmaceuticals Ltd is ₹ 1,385.90 while the 52-week low is ₹ 477.35 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE